US cancer network recommending expensive drugs based on weak evidence, study finds

US cancer network recommending expensive drugs based on weak evidence, study finds
 

Guidelines for American oncologists often recommend expensive and harmful cancer drugs for patients based on “weak evidence”, according to a new study in the British Medical Journal.
The BMJ research looked at drugs recommended for conditions not approved by the US Food and Drug Administration, a practice called “off-label” prescribing.
Off-label prescribing, or using a drug for purposes that may be well known but not approved by a regulatory agency, is common, especially in oncology. But recently approved cancer drugs can cost hundreds of thousands of dollars and have severe side-effects.... read more

 
7 March 2018 in Health, Views: 38
Source: Guardian
Share:
 




News Widget for Webmasters


Realtime News

 

«
»
Mo Tu We Th Fr Sa Su
        1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30